Page last updated: 2024-11-06

prednisolone and Labyrinth Diseases

prednisolone has been researched along with Labyrinth Diseases in 12 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Labyrinth Diseases: Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).

Research Excerpts

ExcerptRelevanceReference
" This paper describes an unusual case in which deafness developed while the patient was receiving topical therapy with prednisolone and homatropine for mild bilateral iritis and right-sided nodular episcleritis."3.67Cogan's syndrome: a treatable cause of neurosensory deafness. ( Bachynski, B; Wise, J, 1984)
"Limb and truncal ataxia, vestibular dysfunction and perceptive deafness were observed."2.38[Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies]. ( Hiraki, Y; Kaji, M; Kuboshiro, T; Kuwasaki, N; Shoji, H, 1989)
"The most common preoperative symptoms, sensorineural hearing loss and vertigo, were notably lacking in more than 30% of patients."1.29Management of the open labyrinth. ( Dornhoffer, JL; Milewski, C, 1995)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19909 (75.00)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, R1
Fujita, A1
Fujimoto, M1
Date, R1
Nishizaki, K1
Naito, Y1
Bachynski, B1
Wise, J1
Pausch, J1
Jäckle, B1
Schmidt, D1
Mann, W1
Milewski, C2
Dornhoffer, J1
DeMeester, C1
Dornhoffer, JL1
Hammer, M1
Witte, T1
Mügge, A1
Wollenhaupt, J1
Laas, J1
Laszig, R1
Zeidler, H1
Vercoe, GS1
Hiraki, Y1
Kuwasaki, N1
Shoji, H1
Kaji, M1
Kuboshiro, T1
McCabe, BF1
Futaki, T1
Semba, T1
Kudo, Y1
Seel, J2
Meyer-Schwickerath, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Trial of Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss[NCT02828033]Early Phase 110 participants (Anticipated)Interventional2017-02-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for prednisolone and Labyrinth Diseases

ArticleYear
[Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies].
    Rinsho shinkeigaku = Clinical neurology, 1989, Volume: 29, Issue:1

    Topics: Adult; Ataxia; Betamethasone; Cerebellar Ataxia; Cranial Nerve Diseases; Humans; Labyrinth Diseases;

1989

Other Studies

11 other studies available for prednisolone and Labyrinth Diseases

ArticleYear
[Long-term follow-up of Cogan's syndrome. Vestibuloauditory symptoms and steroid therapy].
    Nihon Jibiinkoka Gakkai kaiho, 1984, Volume: 87, Issue:12

    Topics: Female; Hearing Loss; Hearing Loss, Bilateral; Humans; Keratitis; Labyrinth Diseases; Middle Aged; P

1984
Cogan's syndrome: a treatable cause of neurosensory deafness.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1984, Volume: 19, Issue:3

    Topics: Child; Deafness; Humans; Iritis; Keratitis; Labyrinth Diseases; Male; Prednisolone; Syndrome; Tropan

1984
[Systemic disease closely related to Cogan's syndrome (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1982, Jul-23, Volume: 107, Issue:29-30

    Topics: Arterial Occlusive Diseases; Cyclophosphamide; Deafness; Female; Fingers; Humans; Keratitis; Labyrin

1982
[Possibilities for preserving hearing in labyrinth fistulas of different degrees of severity].
    Laryngo- rhino- otologie, 1995, Volume: 74, Issue:7

    Topics: Adult; Aged; Anti-Inflammatory Agents; Auditory Threshold; Bone Conduction; Cholesteatoma, Middle Ea

1995
Management of the open labyrinth.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1995, Volume: 112, Issue:3

    Topics: Bone Transplantation; Cartilage; Cholesteatoma, Middle Ear; Female; Fibrin Tissue Adhesive; Fistula;

1995
Complicated Cogan's syndrome with aortic insufficiency and coronary stenosis.
    The Journal of rheumatology, 1994, Volume: 21, Issue:3

    Topics: Adult; Antibodies, Bacterial; Aortic Valve Insufficiency; Chlamydia Infections; Chlamydia trachomati

1994
The effect of early syphilis on the inner ear and auditory nerves.
    The Journal of laryngology and otology, 1976, Volume: 90, Issue:9

    Topics: Adult; Audiometry; Humans; Labyrinth Diseases; Labyrinthitis; Male; Middle Aged; Neuritis; Penicilli

1976
Autoimmune inner ear disease: therapy.
    The American journal of otology, 1989, Volume: 10, Issue:3

    Topics: Autoimmune Diseases; Cyclophosphamide; Drug Therapy, Combination; Humans; Labyrinth Diseases; Predni

1989
Treatment of hydropic patients by immunoglobulin with methyl B12.
    The American journal of otology, 1988, Volume: 9, Issue:2

    Topics: Adult; Aged; Combined Modality Therapy; Drug Resistance; Edema; Endolymphatic Sac; Female; Furosemid

1988
Cogan-I-syndrome. Interstitial keratitis with sudden deafness.
    Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology, 1972, Volume: 185, Issue:4

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Deafness; Humans; Influenza, Human; Kerati

1972
[Cogan-I syndrome: interstitial keratitis with sudden deafness].
    Harefuah, 1973, Nov-15, Volume: 85, Issue:10

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Deafness; Humans; Keratitis; Labyrinth Dis

1973